Meyka Pro banner
Inventiva S.A.

Inventiva S.A. Fundamental Analysis (NASDAQ: IVA)

IVA●NASDAQ
HealthcareBiotechnology
$3.29
$0.24(6.80%)
U.S. Market opens in 10h 22m

Inventiva S.A. Fundamental Analysis (NASDAQ: IVA)

Inventiva S.A. (NASDAQ: IVA) shows moderate financial fundamentals with a PE ratio of -6.16, profit margin of -5042.27%, and ROE of 12.89%. The company generates $0.0B in annual revenue with weak year-over-year growth of -69.55%.

Key Strengths

Cash Position11.03%
PEG Ratio-0.04
Current Ratio3.15

Areas of Concern

Operating Margin-2952.96%
We analyze IVA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -378177.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-378177.3/100

We analyze IVA's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVA struggles to generate sufficient returns from assets.

ROA > 10%
-99.38%

Valuation Score

Excellent

IVA trades at attractive valuation levels.

PE < 25
-6.16
PEG Ratio < 2
-0.04

Growth Score

Moderate

IVA shows steady but slowing expansion.

Revenue Growth > 5%
-69.55%
EPS Growth > 10%
38.31%

Financial Health Score

Excellent

IVA maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.05
Current Ratio > 1
3.15

Profitability Score

Weak

IVA struggles to sustain strong margins.

ROE > 15%
12.89%
Net Margin ≥ 15%
-5042.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVA Expensive or Cheap?

P/E Ratio

IVA trades at -6.16 times earnings. This suggests potential undervaluation.

-6.16

PEG Ratio

When adjusting for growth, IVA's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Inventiva S.A. at -31.33 times its book value. This may indicate undervaluation.

-31.33

EV/EBITDA

Enterprise value stands at -1.43 times EBITDA. This is generally considered low.

-1.43

How Well Does IVA Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-5042.27 as profit after all expenses.

-5042.27%

Operating Margin

Core operations generate -2952.96 in profit for every $100 in revenue, before interest and taxes.

-2952.96%

ROE

Management delivers $12.89 in profit for every $100 of shareholder equity.

12.89%

ROA

Inventiva S.A. generates $-99.38 in profit for every $100 in assets, demonstrating efficient asset deployment.

-99.38%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-20.55M, signaling weaker underlying cash strength.

$-20.55M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-20.60M, restricting financial flexibility.

$-20.60M

FCF Per Share

Each share generates $-0.40 in free cash annually.

$-0.40

FCF Yield

IVA converts -63.67% of its market value into free cash.

-63.67%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.16

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

-31.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

3524.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

12.89

vs 25 benchmark

ROA

Return on assets percentage

-0.99

vs 25 benchmark

ROCE

Return on capital employed

-0.84

vs 25 benchmark

How IVA Stacks Against Its Sector Peers

MetricIVA ValueSector AveragePerformance
P/E Ratio-6.1630.63 Better (Cheaper)
ROE1288.84%570.00% Excellent
Net Margin-504227.30%24326.00% Weak
Debt/Equity-2.050.52 Strong (Low Leverage)
Current Ratio3.155.69 Strong Liquidity
ROA-99.38%-59.00% (disorted) Weak

IVA outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

118.53%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-91.02%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

37.82%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ